EMMA International, a specialist in quality, regulatory, and compliance services for the biotechnology, pharmaceuticals, and medical device industries, has entered a strategic partnership with THEMA, an Italian based strategic-regulatory consulting company focused on medical and IVD devices. 

The goal of this strategic partnership is to expand geographical offerings to companies operating in the life sciences regulated space. 

EMMA CEO Kira Jabri, said: “At EMMA International, we are thrilled to enter into this strategic partnership with THEMA to expand our service offerings in the EU market. This strategic partnership will expand resource offerings to our clients. Together, EMMA International and THEMA bring a wealth of knowledge in regulatory affairs, quality management and product development to the medical device industry.”  

Marisa Testa, CEO of Thema, added: “Through this partnership we can support manufacturers expand in the target markets by analysing their needs, being of help in solving their issues and providing them with the most accurate service within the US and the EU landscape, whether it means providing Local Representative or auditing services or through regulatory strategic support. EMMA International has been able to reach this goal and I believe their staff has put together something we can all rely on. Thanks to them we can now help our clients face the QA/RA challenges in the US market more confidently.”

Through this strategic partnership, EMMA International and Thema will be able to expand their network and capabilities to support manufacturers.